RT Book, Section A1 Tsukada, Hisashi A2 Sugarbaker, David J. A2 Bueno, Raphael A2 Burt, Bryan M. A2 Groth, Shawn S. A2 Loor, Gabriel A2 Wolf, Andrea S. A2 Williams, Marcia A2 Adams, Ann SR Print(0) ID 1170409018 T1 Endoscopic Therapy for Endobronchial Lesions T2 Sugarbaker’s Adult Chest Surgery, 3e YR 2020 FD 2020 PB McGraw-Hill Education PP New York, NY SN 9781260026931 LK accesssurgery.mhmedical.com/content.aspx?aid=1170409018 RD 2023/12/10 AB Central airway obstruction (CAO) is caused by a variety of benign and malignant diseases. In general, a tracheal luminal diameter less than 8 mm will result in exertional dyspneic symptoms and audible stridor; symptoms occur at rest at less than 5 mm.1 Sticky secretions or a mucus plug at the stenotic area may result in the patient potentially becoming symptomatic, even with a tracheal diameter larger than 8 mm, which may become life-threatening. Restoration of airway patency is associated with improvement in symptoms, quality of life, and lung function.2 The treatment of malignant CAO is often a multimodality approach and is usually performed for palliation of symptoms in advanced lung cancer. In contrast, benign CAO disease pathogenesis per se does not influence the patient’s prognosis. Therefore, a more curative intervention option is required, including resection and reconstruction of the airway with an expert team. This chapter reviews currently available endotracheal and endobronchial techniques for the management of CAO in various settings, including balloon tracheobronchoplasty, mechanical airway dilation and core-out, electrocautery, argon plasma coagulation, laser therapy, photodynamic therapy, cryotherapy, brachytherapy, and airway stents. All CAO cases are challenging for the physician. Treatment options will be determined by expertise and available equipment in each institution.